olmesartan has been researched along with Cholera Infantum in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 9 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dong, YH; Gagne, JJ; He, M; Hsieh, PH; Jin, Y; Tsacogianis, TN | 1 |
Dano, H; Henry, P; Jouret-Mourin, A; Piessevaux, H | 1 |
Etminan, M; Eurich, DT; Lin, M; Padwal, R | 1 |
Panarelli, NC | 1 |
Abitbol, V; Bobichon, R; Cadiot, G; Carbonnel, F; Cerf-Bensussan, N; Chayvialle, JA; Colardelle, P; Druez, A; Eoche, M; Gompel, M; Lacroute, J; Malamut, G; Marthey, L; Méresse, B; Mesnard, B; Parlier, D; Peschard, S; Poncin, E; Pouderoux, P; Salloum, H; Savoye, G; Seksik, P; Skinazi, F; Wils, P; Zerbib, F | 1 |
Cartee, A; Marietta, EV; Murray, JA; Rishi, A | 1 |
Brousse, N; Cadiot, G; Carbonnel, F; Cellier, C; Cerf-Bensussan, N; Derrieux, C; Guegan, N; Macintyre, E; Malamut, G; Marthey, L; Meresse, B; Savoye, G; Scialom, S; Seksik, P; Verkarre, V; Vuitton, L | 1 |
Del Val Antoñana, A; Díaz Jaime, FC; Sáez González, E | 1 |
Machado, I; Maia de Alcántara, F; Martínez de Juan, F; Martínez Lapiedra, C; Reolid, M | 1 |
2 review(s) available for olmesartan and Cholera Infantum
Article | Year |
---|---|
Drug-induced injury in the gastrointestinal tract.
Topics: Alendronate; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Antineoplastic Agents, Phytogenic; Bone Density Conservation Agents; Cation Exchange Resins; Colchicine; Ferrous Compounds; Gastrointestinal Diseases; Gastrointestinal Tract; Gout Suppressants; Humans; Imidazoles; Immunosuppressive Agents; Mycophenolic Acid; Paclitaxel; Polystyrenes; Tetracycline; Tetrazoles | 2014 |
Drug-induced enteropathy.
Topics: Antibodies, Monoclonal; Drug-Related Side Effects and Adverse Reactions; Gastrointestinal Diseases; Humans; Imidazoles; Ipilimumab; Mycophenolic Acid; Risk Factors; Tetrazoles | 2015 |
7 other study(ies) available for olmesartan and Cholera Infantum
Article | Year |
---|---|
Use of olmesartan and enteropathy outcomes: a multi-database study.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Celiac Disease; Cohort Studies; Databases, Factual; Diarrhea; Female; Gastrointestinal Diseases; Humans; Imidazoles; Incidence; Male; Middle Aged; Tetrazoles; United States; Weight Loss | 2018 |
[An unusual case of olmesartan induced enteropathy].
Topics: Antihypertensive Agents; Chronic Disease; Dehydration; Diarrhea; Gastrointestinal Diseases; Humans; Imidazoles; Intestinal Mucosa; Male; Middle Aged; Rare Diseases; Tetrazoles; Weight Loss | 2019 |
Comparative effectiveness of olmesartan and other angiotensin receptor blockers in diabetes mellitus: retrospective cohort study.
Topics: Adult; Angiotensin Receptor Antagonists; Cardiovascular Diseases; Cohort Studies; Comorbidity; Diabetes Mellitus; Female; Gastrointestinal Diseases; Hospitalization; Humans; Hypertension; Imidazoles; Male; Middle Aged; Proportional Hazards Models; Registries; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Survival Rate; Tetrazoles; Treatment Outcome; United States | 2014 |
Olmesartan-associated enteropathy: results of a national survey.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Cohort Studies; Data Collection; Diarrhea; Female; France; Gastrointestinal Diseases; Humans; Imidazoles; Intestinal Mucosa; Male; Middle Aged; Tetrazoles | 2014 |
Gastrointestinal Disorder Associated with Olmesartan Mimics Autoimmune Enteropathy.
Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Diagnosis, Differential; Female; Gastrointestinal Diseases; Humans; Imidazoles; Male; Middle Aged; Polyendocrinopathies, Autoimmune; Tetrazoles; Young Adult | 2015 |
Clinical, laboratory, serological, and histological profile of sprue-like enteropathy associated with olmesartan use.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Celiac Disease; Female; Gastrointestinal Diseases; Humans; Imidazoles; Male; Middle Aged; Tetrazoles | 2016 |
Sprue-like enteropathy associated with olmesartan in a patient with villous atrophy, HLA-DQ2 genotype and antinuclear antibodies.
Topics: Aged; Antibodies, Antinuclear; Anticholesteremic Agents; Atrophy; Celiac Disease; Gastrointestinal Diseases; Genotype; HLA-DQ Antigens; Humans; Imidazoles; Male; Tetrazoles | 2016 |